{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T04:28:31Z","timestamp":1790051311012,"version":"4.0.1"},"reference-count":44,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2003,8,1]],"date-time":"2003-08-01T00:00:00Z","timestamp":1059696000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2003,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>To examine the relationship between cancer and development of thrombotic microangiopathy (TM), the medical records of patients with known TM were examined in one institution from January 1981 to December 2002. Nine out of 93 patients with the established diagnosis of TM had active cancer. All nine of those patients had thrombotic thrombocytopenic purpura (TTP). Among those patients, two patients received chemotherapy prior to the development of TTP. Six of the seven patients who received no chemotherapy had extensive bone marrow metastasis and secondary myelofibrosis. There were two patients each with breast cancer, lung cancer, and stomach cancer. Severe anemia and thrombocytopenia with leukoerythroblastosis were prominent clinical features in all six patients. Four patients had neurological (mental) changes and three developed fever, but none had significant renal dysfunction. Upon establishing the diagnosis of TTP, four patients were treated with exchange plasmapheresis (EP) and two patients were treated with chemotherapy because there were no neurological changes. Three patients achieved complete remission of TTP, one with EP alone and two with chemotherapy. The one patient who achieved remission with EP alone was later treated with chemotherapy and survived for 2 1\/2 years. The other three patients treated with EP alone died within 2 months after the diagnosis of TTP. Since TTP occurred in association with bone marrow metastasis and myelofibrosis in six patients among seven chemotherapy-untreated cancer patients, this marrow change was considered to be the possible cause of the development of TTP. It is recommended that all cancer patients with unexplained anemia and thrombocytopenia be evaluated for the coexistence of bone marrow metastasis and TTP.<\/jats:p>","DOI":"10.1634\/theoncologist.8-4-375","type":"journal-article","created":{"date-parts":[[2004,8,24]],"date-time":"2004-08-24T21:38:39Z","timestamp":1093383519000},"page":"375-380","source":"Crossref","is-referenced-by-count":43,"title":["Thrombotic Thrombocytopenic Purpura Associated with Bone Marrow Metastasis and Secondary Myelofibrosis in Cancer"],"prefix":"10.1093","volume":"8","author":[{"given":"Jae C.","family":"Chang","sequence":"first","affiliation":[{"name":"University of California, Irvine College of Medicine and Division of Hematology\/Oncology at UCI Medical Center, Orange, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tahir","family":"Naqvi","sequence":"additional","affiliation":[{"name":"Department of Medicine, Wright State University School of Medicine, Dayton, Ohio, USA, and Hematology and Oncology Section, Good Samaritan Hospital, Dayton, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2003,8,1]]},"reference":[{"key":"2021122209330994500_R1","first-page":"105","article-title":"Thrombotic thrombocytopenic purpura: understanding a disease no longer rare","volume":"316","author":"Moake","year":"1998","journal-title":"Am J Med Sci"},{"key":"2021122209330994500_R2","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/00000441-197404000-00006","article-title":"The association of thrombotic thrombocytopenic purpura with systemic lupus erythematosus: a report of two cases with successful treatment of one","volume":"267","author":"Dekker","year":"1974","journal-title":"Am J Med Sci"},{"key":"2021122209330994500_R3","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0889-8588(18)30514-8","article-title":"Thrombotic thrombocytopenic purpura and related disorders","volume":"4","author":"Ruggenenti","year":"1990","journal-title":"Hematol Oncol Clin North Am"},{"issue":"suppl 1","key":"2021122209330994500_R4","first-page":"699a","article-title":"Coexisting morbidities as a determinant in the outcome of treatment of thrombotic thrombocytopenic purpura (TTP)","volume":"84","author":"Shipstone","year":"1994","journal-title":"Blood"},{"key":"2021122209330994500_R5","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/00005792-198111000-00003","article-title":"Thrombotic thrombocytopenic purpura: report of 25 cases and review of the literature","volume":"60","author":"Ridolfi","year":"1981","journal-title":"Medicine (Baltimore)"},{"key":"2021122209330994500_R6","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S0272-6386(85)80035-4","article-title":"Mitomycin-C nephrotoxicity: a clinico-pathologic study of 17 cases","volume":"6","author":"Giroux","year":"1985","journal-title":"Am J Kidney Dis"},{"key":"2021122209330994500_R7","doi-asserted-by":"crossref","first-page":"215","DOI":"10.7326\/0003-4819-119-3-199308010-00006","article-title":"Recurrent pancytopenia, coagulopathy, and renal failure associated with multiple quinine-dependent antibodies","volume":"119","author":"Maguire","year":"1993","journal-title":"Ann Intern Med"},{"key":"2021122209330994500_R8","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1056\/NEJM198112033052306","article-title":"Nephrotoxicity of cyclosporin A after allogeneic marrow transplantation: glomerular thromboses and tubular injury","volume":"305","author":"Shulman","year":"1981","journal-title":"N Engl J Med"},{"key":"2021122209330994500_R9","doi-asserted-by":"crossref","first-page":"541","DOI":"10.7326\/0003-4819-128-7-199804010-00004","article-title":"Thrombotic thrombocytopenic purpura associated with ticlopidine: a review of 60 cases","volume":"128","author":"Bennett","year":"1998","journal-title":"Ann Intern Med"},{"key":"2021122209330994500_R10","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/S0272-6386(12)81010-9","article-title":"Transplant-associated thrombotic microangiopathy: the role of IgG administration as initial therapy","volume":"23","author":"Hochstetler","year":"1994","journal-title":"Am J Kidney Dis"},{"key":"2021122209330994500_R11","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1177\/039139888801100214","article-title":"Thrombotic microangiopathy of the miscellaneous secondary type responding to plasma exchange in a liver transplant recipient","volume":"11","author":"Valbonesi","year":"1988","journal-title":"Int J Artif Organs"},{"key":"2021122209330994500_R12","first-page":"S51","article-title":"Recurrence of hemolytic uremic syndrome in renal transplant recipients","volume":"19","author":"Hebert","year":"1986","journal-title":"Kidney Int Suppl"},{"key":"2021122209330994500_R13","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1097\/00007890-198710000-00022","article-title":"Cyclosporine-associated thrombotic thrombocytopenic purpura following liver transplantation: successful treatment with plasma exchange","volume":"44","author":"Dzik","year":"1987","journal-title":"Transplantation"},{"key":"2021122209330994500_R14","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/(SICI)1096-8652(199609)53:1<11::AID-AJH3>3.0.CO;2-8","article-title":"Postoperative thrombotic thrombocytopenic purpura following cardiovascular surgeries","volume":"53","author":"Chang","year":"1996","journal-title":"Am J Hematol"},{"key":"2021122209330994500_R15","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/(SICI)1098-1101(1997)12:4<159::AID-JCA1>3.0.CO;2-9","article-title":"Thrombotic thrombocytopenic purpura following coronary artery bypass graft surgery: prospective observations of an emerging syndrome","volume":"12","author":"Pavlovsky","year":"1997","journal-title":"J Clin Apheresis"},{"key":"2021122209330994500_R16","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/1098-1101(2000)15:3<176::AID-JCA4>3.0.CO;2-T","article-title":"Acute thrombotic thrombocytopenic purpura following abdominal surgeries: a report of three cases","volume":"15","author":"Chang","year":"2000","journal-title":"J Clin Apheresis"},{"key":"2021122209330994500_R17","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/00000441-199011000-00006","article-title":"Disseminated intravascular coagulation due to intravenous administration of hetastarch","volume":"300","author":"Chang","year":"1990","journal-title":"Am J Med Sci"},{"key":"2021122209330994500_R18","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/ajh.2830270312","article-title":"Thrombotic thrombocytopenic purpura in human immunodeficiency virus (HIV)-seropositive males","volume":"27","author":"Meisenberg","year":"1988","journal-title":"Am J Hematol"},{"key":"2021122209330994500_R19","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1159\/000041030","article-title":"Mycoplasma-pneuominae-induced thrombotic thrombocytopenic purpura","volume":"103","author":"Bar Meir","year":"2000","journal-title":"Acta Haematol"},{"key":"2021122209330994500_R20","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/00003081-199906000-00020","article-title":"Diagnosis and management of thrombotic microangiopathies during pregnancy","volume":"42","author":"Esplin","year":"1999","journal-title":"Clin Obstet Gynecol"},{"key":"2021122209330994500_R21","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S1068-607X(00)00040-8","article-title":"Thrombotic thrombocytopenic purpura in pregnancy","volume":"7","author":"Mastrobattista","year":"2000","journal-title":"Prim Care Update Ob Gyns"},{"key":"2021122209330994500_R22","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1055\/s-2007-994923","article-title":"Thrombotic microangiopathy manifesting as thrombotic thrombocytopenic purpura\/hemolytic uremic syndrome in the cancer patient","volume":"25","author":"Gordon","year":"1999","journal-title":"Semin Thromb Hemost"},{"key":"2021122209330994500_R23","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1002\/1097-0142(19811015)48:8<1738::AID-CNCR2820480808>3.0.CO;2-E","article-title":"Microangiopathic hemolytic anemia, thrombocytopenia, and renal failure in patients treated for adenocarcinoma","volume":"48","author":"Kressel","year":"1981","journal-title":"Cancer"},{"key":"2021122209330994500_R24","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/00000421-200002000-00021","article-title":"Thrombotic thrombocytopenic purpura in metastatic carcinoma of the breast","volume":"23","author":"Bubnoff","year":"2000","journal-title":"Am J Clin Oncol"},{"key":"2021122209330994500_R25","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1002\/1097-0142(1971)28:5<1314::AID-CNCR2820280534>3.0.CO;2-D","article-title":"Renal toxicity in man treated with mitomycin C","volume":"28","author":"Liu","year":"1971","journal-title":"Cancer"},{"key":"2021122209330994500_R26","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/ajh.2830500404","article-title":"Hemostatic abnormalities and increased vascular endothelial cell markers in patients with red cell fragmentation syndrome induced by mitomycin C","volume":"50","author":"Nagaya","year":"1995","journal-title":"Am J Hematol"},{"key":"2021122209330994500_R27","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1002\/1097-0142(19941201)74:11<3059::AID-CNCR2820741125>3.0.CO;2-Z","article-title":"Cisplatin-associated hemolytic uremic syndrome","volume":"74","author":"Canpolat","year":"1994","journal-title":"Cancer"},{"key":"2021122209330994500_R28","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1002\/(SICI)1096-8652(199908)61:4<268::AID-AJH9>3.0.CO;2-O","article-title":"Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome (TTP-HUS) following treatment with deoxycoformycin in a patient with cutaneous T-cell lymphoma (Sezary syndrome): a case report","volume":"61","author":"Leach","year":"1999","journal-title":"Am J Hematol"},{"key":"2021122209330994500_R29","doi-asserted-by":"crossref","first-page":"41","DOI":"10.7326\/0003-4819-101-1-41","article-title":"Thrombotic microangiopathy and renal failure associated with antineoplastic chemotherapy","volume":"101","author":"Jackson","year":"1984","journal-title":"Ann Intern Med"},{"key":"2021122209330994500_R30","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/ajh.2830210309","article-title":"Thrombotic thrombocytopenic purpura subsequent to acute myelogenous leukemia chemotherapy","volume":"21","author":"Byrnes","year":"1986","journal-title":"Am J Hematol"},{"key":"2021122209330994500_R31","doi-asserted-by":"crossref","first-page":"570","DOI":"10.4065\/74.6.570","article-title":"Cancer chemotherapy-related thrombotic thrombocytopenic purpura: biological evidence of increased nitric oxide production","volume":"74","author":"Porta","year":"1999","journal-title":"Mayo Clin Proc"},{"key":"2021122209330994500_R32","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1080\/00325481.1990.11704541","article-title":"White clot syndrome: a serious complication of heparin therapy","volume":"87","author":"Chang","year":"1990","journal-title":"Postgrad Med"},{"key":"2021122209330994500_R33","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1182\/blood.V67.1.27.27","article-title":"A diagnostic test for heparin-induced thrombocytopenia","volume":"67","author":"Sheridan","year":"1986","journal-title":"Blood"},{"key":"2021122209330994500_R34","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1046\/j.1365-2141.1996.407945.x","article-title":"Pathogenicity of IgA and\/or IgM antibodies to heparin-PF4 complexes in patients with heparin-induced thrombocytopenia","volume":"92","author":"Amiral","year":"1996","journal-title":"Br J Haematol"},{"key":"2021122209330994500_R35","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0002-9343(99)00286-7","article-title":"Improved survival with plasma exchange in patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome","volume":"107","author":"Lara","year":"1999","journal-title":"Am J Med"},{"key":"2021122209330994500_R36","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1001\/archinte.1987.00370120058012","article-title":"Efficacy of intensive plasmapheresis in thrombotic thrombocytopenic purpura","volume":"147","author":"Lichtin","year":"1987","journal-title":"Arch Intern Med"},{"key":"2021122209330994500_R37","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1046\/j.1365-2141.2000.01941.x","article-title":"Management of thrombotic thrombocytopenic purpura","volume":"109","author":"Rock","year":"2000","journal-title":"Br J Haematol"},{"key":"2021122209330994500_R38","first-page":"140","article-title":"Cancer- and drug-associated thrombotic thrombocytopenic purpura and hemolytic uremic syndrome","volume":"34","author":"Gordon","year":"1997","journal-title":"Semin Hematol"},{"key":"2021122209330994500_R39","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/00005792-197909000-00004","article-title":"Microangiopathic hemolytic anemia and cancer: a review","volume":"58","author":"Antman","year":"1979","journal-title":"Medicine (Baltimore)"},{"key":"2021122209330994500_R40","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1056\/NEJM199811263392202","article-title":"von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome","volume":"339","author":"Furlan","year":"1998","journal-title":"N Engl J Med"},{"key":"2021122209330994500_R41","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1056\/NEJM199811263392203","article-title":"Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura","volume":"339","author":"Tsai","year":"1998","journal-title":"N Engl J Med"},{"key":"2021122209330994500_R42","doi-asserted-by":"crossref","first-page":"41059","DOI":"10.1074\/jbc.C100515200","article-title":"Structure of von Willebrand factor-cleaving protease (ADAMTS13), a metalloprotease involved in thrombotic thrombocytopenic purpura","volume":"276","author":"Zheng","year":"2001","journal-title":"J Biol Chem"},{"key":"2021122209330994500_R43","first-page":"9N","article-title":"Abnormalities of von Willebrand factor multimers in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome","volume":"87","author":"Moake","year":"1989","journal-title":"Am J Med"},{"key":"2021122209330994500_R44","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1172\/JCI112736","article-title":"Involvement of large plasma von Willebrand factor (vWF) multimers and unusually large vWF forms derived from endothelial cells in shear stress-induced platelet aggregation","volume":"78","author":"Moake","year":"1986","journal-title":"J Clin Invest"}],"container-title":["The Oncologist"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1634\/theoncologist.8-4-375","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1634\/theoncologist.8-4-375","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/8\/4\/375\/41840179\/oncolo_8_4_375.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/8\/4\/375\/41840179\/oncolo_8_4_375.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,22]],"date-time":"2021-12-22T16:44:42Z","timestamp":1640191482000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/oncolo\/article\/8\/4\/375\/6387168"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,8,1]]},"references-count":44,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2003,8,1]]},"published-print":{"date-parts":[[2003,8,1]]}},"URL":"https:\/\/doi.org\/10.1634\/theoncologist.8-4-375","relation":{},"ISSN":["1083-7159","1549-490X"],"issn-type":[{"value":"1083-7159","type":"print"},{"value":"1549-490X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2003,8,1]]},"published":{"date-parts":[[2003,8,1]]}}}